$6.1 million in grants pave way for TGen-led studies of deadly lung diseases Posted Wednesday March 27, 2019 50,000 U.S. patients annually diagnosed with Idiopathic Pulmonary Fibrosis
TGen Physician-In-Chief receives Distinguished Public Service Award from AACR Posted Tuesday March 26, 2019 Dr. Daniel Von Hoff recognized for ‘extraordinary clinical research career’
As if by magic: TGen develops program that lights up cancer-causing mutations Posted Wednesday March 20, 2019 LumosVar — a name inspired by Harry Potter — could help physicians provide genomic-based treatments for their patients
TGen and ABL pursue global rollout of advanced TB test Posted Monday March 18, 2019 Licensing agreement puts DeepChek®-TB one step closer to clinical application
TGen plays key role in identifying foothold for leveraging cancer cell weakness Posted Monday March 4, 2019 Nationwide effort reveals potential treatment option for pancreatic cancer
Wendy’s® $1 Jr. Frosty® Offer Benefits TGen Cancer Research Posted Monday March 4, 2019 More than $1.5 million donated through the Bernice E. Holland Foundation
TGen Associate Professor and Director of Scientific Operations recognized as one of Arizona’s Outstanding Women in Business Posted Wednesday February 13, 2019 Dr. Winnie Liang will be honored April 4 by the Phoenix Business Journal
TGen Women’s Philanthropy Council invites inaugural members Posted Monday January 28, 2019 Council ‘Fuels the Future of Medicine’ by supporting promising new biomedical research at TGen
Outbreak of paralyzing disease linked to non-polio enterovirus through TGen-led study Posted Tuesday January 22, 2019 EV-D68 is confirmed among AFM patients at Phoenix-area hospital
NAU-TGen study finds West Nile Virus now a permanent part of Arizona ecosystem Posted Tuesday January 15, 2019 New technology allows better tracking of potentially deadly infection